Low-dose aspirin and incident atrial fibrillation in healthy older individuals: a post-hoc analysis of the ASPREE Trial.
Jocasta BallJ T NeumannA M TonkinP KirchhofBen FreedmanA BrodtmannC ReidM R NelsonLawrence J BeilinS FitzgeraldD StubR L WoodsJ J McNeilPublished in: European heart journal. Cardiovascular pharmacotherapy (2023)
Keyphrases
- low dose
- atrial fibrillation
- phase iii
- high dose
- study protocol
- cardiovascular disease
- oral anticoagulants
- phase ii
- catheter ablation
- left atrial
- community dwelling
- clinical trial
- middle aged
- left atrial appendage
- physical activity
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- open label
- randomized controlled trial
- type diabetes
- coronary artery disease
- cardiovascular events
- venous thromboembolism
- placebo controlled